aflibercept

Related by string. Aflibercept * * evaluating aflibercept . aflibercept VEGF Trap . Aflibercept VEGF Trap *

Related by context. All words. (Click for frequent words.) 73 iniparib 71 Amrubicin 71 Aflibercept 71 glufosfamide 71 ELACYT 71 Ixempra 70 docetaxel chemotherapy 70 Panzem R NCD 70 Canvaxin 70 Targretin 70 Fludara 70 pertuzumab 70 mapatumumab 70 enzastaurin 70 VEGF Trap 70 dacetuzumab 70 sorafenib Nexavar 70 pomalidomide 69 ridaforolimus 69 adecatumumab 69 axitinib 69 oral ridaforolimus 69 phase IIb clinical 69 temsirolimus 69 bevacizumab Avastin 69 Jevtana 69 sorafenib tablets 69 BAY #-# 69 MAGE A3 ASCI 69 Hycamtin 69 perifosine 68 Velcade bortezomib 68 ocrelizumab 68 Vectibix 68 Onrigin 68 Asentar 68 Nexavar sorafenib 68 elotuzumab 68 T DM1 68 neratinib 68 Allovectin 7 68 ZOLINZA 68 cediranib 68 JAK inhibitor 68 Bezielle 68 YONDELIS 68 docetaxel Taxotere R 68 INCB# [001] 68 vandetanib 68 cetuximab Erbitux 68 bosutinib 68 EndoTAGTM 1 68 custirsen 68 sunitinib malate 67 carboplatin paclitaxel 67 pegylated interferon alpha 67 valopicitabine 67 forodesine 67 Allovectin 7 ® 67 SinuNase 67 Cloretazine 67 Erbitux cetuximab 67 gemcitabine chemotherapy 67 Dacogen injection 67 FOLFIRI 67 Amigal 67 CIMZIA TM 67 Corlux 67 bendamustine 67 HGS# 67 Tarceva TM 67 Herceptin trastuzumab 67 Nexavar ® 67 AEGR 67 dasatinib 67 zalutumumab 67 pazopanib 67 Revlimid lenalidomide 67 sunitinib 67 Gemzar ® 67 cabazitaxel 66 bevacizumab Avastin ® 66 Pemetrexed 66 Xelox 66 standard chemotherapy regimen 66 docetaxel Taxotere ® 66 Phase Ib 66 elesclomol 66 BRAF inhibitor 66 ixabepilone 66 ganetespib 66 HER2 positive metastatic breast 66 Phenoptin 66 Mipomersen 66 Doxil ® 66 gemcitabine carboplatin 66 metastatic HRPC 66 Genentech Roche 66 daclizumab 66 GSK# [001] 66 Taxotere ® 66 celgosivir 66 OncoVEX GM CSF 66 Pegintron 66 ASA# 66 BRIM2 66 infusional 5-FU/LV 66 amrubicin 66 alvespimycin 66 HuMax EGFr 66 Taxol paclitaxel 66 sapacitabine 66 Telcyta 66 YERVOY 66 Alocrest 66 evaluating tivozanib 66 Glufosfamide 66 active comparator 66 UPLYSO 66 GVAX 66 plus prednisone 66 FTY# 66 methylnaltrexone 66 ACTEMRA TM 66 sorafenib Nexavar ® 66 Tocosol Paclitaxel 66 pradefovir 66 R sorafenib tablets 66 KRN# 66 decitabine 66 MGd 66 Temsirolimus 66 Folfox 65 CIMZIA ™ 65 rNAPc2 65 Nexavar 65 Taxotere chemotherapy 65 ToGA 65 Cloretazine R VNP#M 65 ZACTIMA 65 EndoTAG TM -1 65 mycophenolate mofetil 65 ponatinib 65 galiximab 65 motesanib 65 Advexin 65 OvaRex ® MAb 65 NXL# 65 calcineurin inhibitors 65 Tekamlo 65 Satraplatin 65 Torisel 65 Irinotecan 65 metastatic hormone refractory 65 lumiliximab 65 Zolinza 65 Phase Ib II 65 relapsed ovarian cancer 65 capecitabine Xeloda R 65 cangrelor 65 topotecan 65 trastuzumab DM1 65 boosted protease inhibitor 65 Fibrillex TM 65 Taxotere docetaxel 65 pegylated interferon alfa 2b 65 Phase IIb clinical trials 65 HRPC 65 pegloticase 65 CoFactor 65 CANCIDAS 65 REOLYSIN ® 65 Aplidin 65 comparator arm 65 albinterferon alfa 2b 65 sorafenib Nexavar R 65 ELND# 65 bortezomib Velcade 65 HuMax CD4 65 HGS ETR1 65 dexpramipexole 65 NVA# 65 sunitinib Sutent 65 trastuzumab DM1 T DM1 65 chemotherapeutic regimen 65 XELOX 65 CA4P 65 tremelimumab 65 DEB# 65 TELCYTA 65 pralatrexate 65 BCIRG 65 tenofovir emtricitabine 65 Clolar ® 65 pain palliation 65 PXD# 65 AEG# 65 midstage clinical 65 Pfizer Sutent 65 relapsed multiple myeloma 65 anidulafungin 65 figitumumab 65 plus gemcitabine 65 tesmilifene 65 Aptivus ® 65 bicifadine 65 anti TNF 65 CIMZIA TM certolizumab pegol 65 oral antiviral 65 TREANDA 65 Panitumumab 65 aflibercept VEGF Trap 65 nab paclitaxel 65 vicriviroc 65 TRO# 65 platinum refractory 65 IMC A# 65 Azixa 65 Erbitux 64 afatinib 64 dirucotide 64 Fludara ® 64 mertansine 64 huC# DM4 64 brentuximab vedotin 64 Xanafide 64 PSMA ADC 64 OPAXIO 64 GLPG# 64 Rituxan rituximab 64 Imprime PGG 64 azacitidine 64 PRT# 64 TTF Therapy 64 oral deforolimus 64 tecarfarin 64 L BLP# 64 registrational trial 64 Troxatyl 64 trastuzumab Herceptin R 64 Diamyd ® 64 interferon gamma 1b 64 phase IIa clinical 64 pegylated interferons 64 ThermoDox R 64 dalbavancin 64 posaconazole 64 paclitaxel carboplatin 64 Copegus ribavirin 64 TLK# 64 carfilzomib 64 thalidomide Thalomid 64 IMA# 64 regorafenib 64 tanespimycin 64 dexanabinol 64 teriflunomide 64 EOquin TM 64 Sanofi Aventis Taxotere 64 pegylated liposomal doxorubicin 64 Taxotere R 64 TNFerade 64 Archexin 64 EFAPROXYN 64 Vidaza azacitidine 64 dose cohort 64 rituximab Rituxan 64 FOLFOX4 64 CINTREDEKIN BESUDOTOX 64 vidofludimus 64 Sandostatin LAR Depot 64 iclaprim 64 OvaRex 64 Phase Ib study 64 IL# PE#QQR 64 estramustine 64 ularitide 64 panitumumab 64 NEUPOGEN 64 SPRYCEL ® 64 Viramidine 64 fluoropyrimidine 64 lintuzumab 64 clevidipine 64 picoplatin 64 PDE4 inhibitor 64 plus dexamethasone 64 atacicept 64 Vectibix panitumumab 64 carboplatin 64 cilengitide 64 EGFR TKI 64 Folotyn 64 PEG PAL 64 TELINTRA 64 Avastin bevacizumab 64 Xcytrin 64 Azedra 64 viral kinetic 64 phase IIb 64 fidaxomicin 64 RG# [001] 64 deforolimus 64 Allovectin 7 R 64 evaluating Xcytrin 64 recurrent glioblastoma multiforme 64 5 fluorouracil leucovorin 64 brivaracetam 64 ofatumumab 64 vorinostat 64 evaluating T DM1 64 TORISEL 64 SAR# [004] 64 Golimumab 64 EOquin 64 Theratope 64 alvimopan 64 oxaliplatin Eloxatin 64 Virulizin ® 64 Tamibarotene 64 PegIntron 64 Diovan HCT 64 VNP#M 64 TACI Ig 64 terlipressin 64 Randomized Phase 64 Sym# 64 Vernakalant 64 ruboxistaurin 64 abatacept 64 orBec 64 phase Ib 64 Vandetanib 64 docetaxel Taxotere 64 Ceflatonin 64 interferon alfa 64 velafermin 64 dacarbazine 64 mRCC 64 Aloxi injection 64 oxymorphone ER 64 Proellex TM 64 capecitabine Xeloda 64 elacytarabine 64 Doxil 64 TBC# 64 ATACAND 64 refractory chronic lymphocytic 64 ANYARA 64 Bicifadine 64 Tasigna nilotinib 63 Bayer Onyx 63 HCD# [002] 63 relapsed myeloma 63 Tavocept 63 Omacetaxine 63 PrevOnco 63 TNF inhibitor 63 chlorambucil 63 Xeloda ® 63 Neupogen ® 63 tocilizumab 63 radiation sensitizer 63 Pimavanserin 63 MyVax 63 RSD# oral 63 peginesatide 63 IV Busulfex 63 systemic ALCL 63 docetaxel prednisone 63 MOZOBIL 63 lesinurad 63 palonosetron 63 Dasatinib 63 Tykerb lapatinib 63 ipilimumab 63 Genasense ® 63 HuMax CD# 63 HCV SPRINT 63 mTOR inhibitor 63 regadenoson 63 RhuDex ® 63 PROMACTA 63 APTIVUS r 63 seliciclib 63 Dacogen 63 ORENCIA ® 63 trabectedin 63 Laquinimod 63 irbesartan 63 Telaprevir 63 Fodosine 63 dacarbazine chemotherapy 63 PLK1 SNALP 63 FOLOTYN 63 Proxinium TM 63 Starlix 63 Daclizumab 63 LymphoStat B belimumab 63 standard chemotherapy regimens 63 PEG SN# 63 PDX pralatrexate 63 Peginterferon alfa 2b 63 Phase 1b 63 Bortezomib 63 Perifosine 63 vismodegib 63 metastatic renal cell carcinoma 63 ImClone Erbitux 63 lenalidomide dexamethasone 63 obatoclax 63 DU #b 63 Erlotinib 63 VIDAZA 63 ELOXATIN 63 Pazopanib 63 oral cladribine 63 INTEGRILIN 63 melphalan prednisone 63 abiraterone acetate 63 Cloretazine ® 63 thymalfasin 63 HGS ETR2 63 gefitinib Iressa 63 ERBITUX 63 EGFR expressing mCRC 63 histone deacetylase HDAC inhibitor 63 Gleevec imatinib mesylate 63 XGEVA 63 satraplatin 63 alfa 2a 63 mCRC patients 63 Phase 2a trial 63 Dacogen decitabine 63 chemotherapy FOLFOX 63 Aurexis 63 trastuzumab emtansine T DM1 63 Muraglitazar 63 daptomycin 63 fingolimod 63 biologic therapy 63 pegylated interferon peg IFN 63 paclitaxel Taxol ® 63 Phase Ib clinical 63 temozolomide 63 Genasense 63 DSMB 63 SUTENT ® 63 metaglidasen 63 tolevamer 63 Zadaxin 63 AP# [003] 63 gemcitabine Gemzar 63 antibody MAb 63 cetuximab Erbitux ® 63 GRN# 63 RSR# 63 SCCHN 63 assessing T DM1 63 pegylated interferon alpha 2a 63 TRISENOX 63 vemurafenib 63 peginterferon 63 Genentech Rituxan 63 EDEMA3 63 nalbuphine ER 63 chronic angina 63 danoprevir 63 PEG Interferon lambda 63 Bevacizumab 63 Tarceva erlotinib 63 oral methylnaltrexone 63 TASKi3 63 rilpivirine 63 Hyphanox 63 INC# 63 cinacalcet HCl 63 Dapagliflozin 63 phase IIb trial 63 metastatic colorectal 63 atrasentan 63 phase IIa 63 Civacir 63 Tesetaxel 63 Ozarelix 63 SinuNase TM 63 Amgen Vectibix 63 OncoVEX 63 Ambrisentan 63 Plicera 63 QTc prolongation 63 GALNS 63 IRX 2 63 Mitoxantrone 63 Arimidex anastrozole 63 Roche Xeloda 63 Cancidas 63 Phase 2b study 63 Itopride 63 Ocrelizumab 63 Tarceva 63 Apixaban 63 farletuzumab 63 ongoing Phase 1b 63 Dalbavancin 63 Romidepsin 63 Targretin capsules 63 voreloxin 63 RAPTIVA 63 ancrod 63 low dose cytarabine 63 CR# vcMMAE 63 Fibrin Pad 63 FOLFOX6 chemotherapy regimen 63 DexaSite 63 PEG INTRON 63 Sprycel dasatinib 63 Orazol 63 solanezumab 63 incyclinide 63 Pivotal Phase III 63 Femara letrozole 62 hormone refractory metastatic prostate 62 Omnitarg 62 AVONEX ® 62 Gleevec imatinib 62 Xinlay 62 placebo controlled Phase III 62 Sorafenib 62 Seliciclib 62 raltegravir 62 Zarnestra 62 subcutaneously administered 62 Solazed 62 SUCCEED trial 62 cetuximab 62 esophageal candidiasis 62 talactoferrin 62 Mylotarg 62 clodronate 62 peg IFN 62 Phase 1b clinical 62 rFVIIa 62 selective androgen receptor modulator 62 PROSTVAC TM 62 Onconase 62 5-FU/LV 62 Proleukin 62 fluvastatin 62 ARCALYST ® 62 eniluracil 62 lenalidomide Revlimid 62 refractory gout 62 eltrombopag 62 RezularTM 62 LY# [003] 62 cetuximab Erbitux R 62 xanthine oxidase inhibitor 62 concurrent chemoradiation 62 Pruvel 62 eprotirome 62 vinorelbine 62 levosimendan 62 Campath alemtuzumab 62 recurrent ovarian cancer 62 BEACOPP 62 STRIDE PD 62 Elotuzumab 62 ximelagatran 62 ritonavir boosted 62 Actemra 62 Octreolin 62 DASISION 62 Treanda 62 Panzem 62 OZURDEX ® 62 SNT-MC#/idebenone 62 Phase IIIb clinical 62 sorafenib 62 MYDICAR ® 62 eribulin 62 Neulasta ® 62 monotherapy 62 alkylating agent 62 anti arrhythmic 62 FOLFOX 62 SNT MC# 62 Ophena TM 62 ADVEXIN 62 uric acid lowering 62 Gemzar gemcitabine 62 adalimumab Humira 62 fenofibric acid 62 Noxafil 62 Betaferon ® 62 PegIFN RBV 62 DOXIL 62 LAF# 62 IMGN# 62 Pixuvri 62 KNS # 62 TOCOSOL Paclitaxel 62 Ramoplanin 62 evaluating satraplatin 62 Fablyn 62 gadobutrol 62 KRAS status 62 targeted radiotherapeutic 62 multicenter Phase II 62 aleglitazar 62 alpha interferons 62 entecavir 62 Diamyd R 62 Neurodex 62 LibiGel Phase III 62 idraparinux 62 Sprycel 62 apaziquone 62 nilotinib 62 Exforge HCT 62 Specifid 62 metastatic castration resistant 62 placebo dexamethasone 62 OHR/AVR# 62 non nucleoside inhibitor 62 Phase III clinical 62 sargramostim 62 AZILECT R 62 metastatic renal cell 62 sitaxsentan 62 pan HDAC inhibitor 62 Eribulin 62 OvaRex R 62 metastatic GIST 62 Fx #A 62 Pertuzumab 62 FOLOTYN ® 62 PTK ZK 62 KRAS mutations occur 62 relapsed MM 62 proteasome inhibitor 62 lapatinib Tykerb 62 IIa trial 62 PhosLo 62 Teriflunomide 62 placebo controlled clinical 62 dimebon 62 anthracyclines taxanes 62 APPRAISE 62 Novartis Zometa 62 panitumumab Vectibix 62 Alimta pemetrexed 62 Tekturna HCT 62 tigecycline 62 Naproxcinod 62 Retisert TM 62 Onco TCS 62 telaprevir VX 62 Cetuximab 62 Balaglitazone 62 Paraplatin ® 62 riociguat 62 alemtuzumab Campath 62 ISENTRESS 62 HCV RESPOND 2 62 liposomal formulation 62 ASONEP 62 pemetrexed Alimta 62 APTIVUS 62 Rasilez Tekturna 62 Combidex 62 Hematide 62 Xibrom TM 62 immunomodulatory therapy 62 PTK# 62 Traficet EN 62 otelixizumab 62 Safinamide 62 ozarelix 62 Trexima 62 alpha 2a 62 PS# [001] 62 Syncria 62 induced macular edema 62 Avastin 62 Faslodex 62 TroVax 62 LUX Lung 62 Zalbin 62 docetaxel 62 PRX # 62 talabostat 62 AzaSite Plus 62 Phase #b/#a clinical 62 ENDEAVOR IV 62 HuLuc# 62 Ceplene/IL-2 62 Zerenex 62 Cethromycin 62 nitazoxanide 62 Abiraterone acetate 62 PREZISTA r 62 Phase #b/#a 62 Lung Rx 62 corticosteroid dexamethasone 62 Renal Cell Carcinoma RCC 62 erlotinib Tarceva 62 ruxolitinib 62 CDP# 62 Panzem NCD 62 nonsmall cell lung cancer 62 fostamatinib 62 AGILECT R 62 relapsed CLL 62 zanolimumab 62 ACUITY trial 62 VFEND 62 CBLC# 62 MyVax R 62 Romiplostim 62 Promacta 62 TEMODAL 62 Phase III randomized controlled 62 metastatic CRC 62 interferon ribavirin 62 RITUXAN 62 Pirfenidone 62 CLARITY study 62 taxane 62 FROVA 62 midstage studies 62 adalimumab 61 Camptosar ® 61 dose escalation Phase 61 pemetrexed 61 Afatinib 61 Hepatocellular Carcinoma HCC 61 Trovax 61 efficacy endpoint 61 budesonide foam 61 R#/MEM # 61 Candesartan 61 Neulasta R 61 bazedoxifene 61 ANA# 61 tipranavir 61 CEQ# 61 oral prodrug 61 Roche Pegasys 61 Chemophase 61 Wyeth Progenics 61 BZL# 61 ADAGIO study 61 Camptosar 61 almorexant 61 goserelin 61 ISIS # 61 betrixaban 61 LibiGel ® 61 Navelbine 61 Aliskiren 61 pharmacokinetic PK study 61 LymphoStat B TM 61 Abraxane 61 Prosaptide 61 CALGB # [002] 61 voclosporin 61 Azacitidine 61 cancer mCRC 61 XL# XL# XL# XL# 61 MEK Inhibitor 61 Arixtra 61 TYKERB 61 bevacizumab 61 BLP# Liposome Vaccine 61 Ranolazine 61 abiraterone 61 investigational monoclonal antibody 61 Phase IIa clinical 61 telaprevir 61 TKM ApoB 61 Telintra 61 Proquin XR 61 fosbretabulin 61 mg/m2 dose 61 Celgene Revlimid 61 BCR ABL inhibitor 61 gemcitabine cisplatin 61 Lenalidomide 61 dosing cohort 61 Ixabepilone 61 Pegasys peginterferon alfa 2a 61 Zybrestat 61 AVASTIN 61 torezolid phosphate 61 ZYBRESTAT 61 INTEGRILIN ® 61 Aryplase 61 Epivir HBV 61 UVIDEM 61 tasimelteon 61 FOLPI 61 Alzhemed TM 61 Catena ® 61 MAXY G# 61 cytokine refractory 61 Meets Primary Endpoint 61 apremilast 61 Pralatrexate 61 Peg IFN 61 lenalidomide Revlimid R 61 Cytoxan 61 AZT zidovudine Retrovir 61 APTIVUS R 61 NATRECOR R 61 BR.# 61 Tolamba 61 JANUVIA 61 Tezampanel 61 Yervoy 61 ONGLYZA ™ 61 darapladib 61 Pivotal Phase 61 relapsing multiple sclerosis 61 oxycodone CR 61 INCB# [003] 61 ONTAK 61 cisplatin vinorelbine 61 erlotinib Tarceva ® 61 ThermoDox ® 61 vinflunine 61 Triapine 61 tubulin inhibitor 61 volociximab 61 Sutent sunitinib 61 immunotherapeutic agent 61 acyclovir Lauriad R 61 palifermin 61 placebo controlled Phase 61 Cimzia TM 61 Hycamtin ® 61 YONDELIS R 61 Eculizumab 61 ORENCIA R 61 Votrient 61 Telavancin 61 Maribavir 61 gefitinib 61 Phase 1b trial 61 Campath ® 61 TYZEKA 61 Trastuzumab 61 Orathecin 61 Epoetin alfa 61 indacaterol 61 interferon therapy 61 opioid induced bowel dysfunction 61 bortezomib 61 Natalizumab 61 Elvitegravir 61 metastatic colorectal cancer 61 romidepsin 61 PREZISTA rtv 61 visilizumab 61 FOLFIRINOX 61 LymphoStat B 61 Arcalyst 61 SUTENT 61 Velcade 61 sipuleucel T 61 faropenem 61 Leukine ® 61 unblinded 61 MDV# 61 THALOMID 61 budiodarone 61 DPP4 inhibitor 61 Prestara 61 olaparib 61 vinca alkaloid 61 Phase IIa trials 61 BEMA TM Fentanyl 61 CYPHER Stent 61 lorvotuzumab mertansine 61 Arimoclomol 61 octreotide LAR 61 IFN alfa 61 AQ4N 61 Xyotax 61 Inhalation Solution 61 prostate cancer HRPC 61 tipifarnib 61 Navelbine ® 61 VELCADE melphalan 61 5 FU leucovorin 61 virus HCV protease inhibitor 61 Uvidem 61 Gliadel Wafer 61 Tygacil 61 GAMMAGARD 61 SCH # 61 ATL# [001] 61 Hsp# Inhibitor 61 Hedgehog Pathway Inhibitor 61 Arzerra 61 Immunotherapeutic 61 antiplatelet agent 61 rindopepimut 61 Enzastaurin 61 Atrasentan 61 Tykerb 61 CCX# 61 clazosentan 61 Topotecan 61 Phase IIb trial 61 Pafuramidine 61 INTELENCE 61 Ziopharm 61 Annamycin 61 refractory metastatic 61 sevelamer 61 Elocalcitol 61 motesanib diphosphate 61 CALGB 61 Cloretazine R 61 Degarelix 61 mitoxantrone 61 Adventrx 61 Platinol 61 subcutaneous formulation 61 paclitaxel Taxol 61 SILENOR 61 BioNumerik 61 Exelixis compounds 61 anthracycline taxane 61 AVADO 61 Omigard 61 mTOR inhibitors 61 Angiomax monotherapy 61 Actos pioglitazone 61 INSPIRE Trial Phase III 61 Increlex R 61 Zactima 61 placebo controlled studies 61 PF # [001] 61 odanacatib 61 Stimuvax 61 MGCD# [001] 61 6R BH4 61 Ophena 61 metastatic castrate resistant 61 telbivudine 61 Alkeran 61 silodosin 61 ribavirin RBV 61 Elitek 61 eribulin mesylate 61 glatiramer 61 briakinumab 61 Epirubicin 61 Sulonex 61 relapsed SCLC 61 iSONEP 61 TNF antagonist 61 Cinquil 61 BARACLUDE R 61 recurrent NSCLC 61 Tolvaptan 61 PF # [002] 61 mg kg dose 61 BARACLUDE ® 61 efalizumab 61 Zometa zoledronic acid 61 romiplostim 61 RELOVAIR ™ 61 GW# [003] 61 randomized Phase III 61 leucovorin 61 TAXOTERE ® 61 GVAX immunotherapy 61 baminercept 61 fallopian tube carcinoma 61 Urocidin 61 antithrombotics 61 muraglitazar 61 FOLFOX chemotherapy 61 Icatibant 61 non squamous NSCLC 61 metastatic pancreatic 61 HCV protease inhibitor 61 VAPRISOL 61 refractory APL 61 relapsing MS 61 Avastin Tarceva 61 CTAP# Capsules 61 lintuzumab SGN 61 Rasagiline 60 Eloxatin ® 60 taribavirin

Back to home page